Screening for Lynch Syndrome: Optimal Strategies and Performance Remain a Moving Target
- PMID: 36735557
- PMCID: PMC9907004
- DOI: 10.14309/ajg.0000000000002132
Screening for Lynch Syndrome: Optimal Strategies and Performance Remain a Moving Target
References
-
- Westfall JM, Mold J, Fagnan L. Practice-based research--”Blue Highways” on the NIH roadmap. JAMA. 2007;297(4):403–406. - PubMed
-
- Mathew P, Michelle G, Karen GS. The effectiveness of clinical guideline implementation strategies – a synthesis of systematic review findings. Journal of evaluation in clinical practice. 2008;14(5):888–897. - PubMed
-
- Evaluation of Genomic Applications in P, Prevention Working G. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet. Med 2009; 11: 35–41 - PMC - PubMed
-
- Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest. Endosc 2014; 80: 197–220. - PubMed
-
- Stone JK, Winter R, Khan D, et al. A Canadian Provincial Screening Program for Lynch Syndrome. AJG-22-1038-R1 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
